Micropolis Holding Co. (“Micropolis” or the “Company”) (NYSE: MCRP), a pioneer in unmanned ground vehicles and AI-driven ...

FLYING COLOURS INVESTMENT MANAGEMENT LIMITED, operating under the brand name DNMiner, has reaffirmed its position as a ...

Thunderbit's roadmap includes the release of Auto Data Extraction Agents capable of monitoring and updating datasets ...

CHICAGO, May 8, 2025 /PRNewswire/ -- The Society for Sales and Marketing Professionals in Science (SAMPS), in partnership ...

Cardio Diagnostics Holdings, Inc. ("Cardio" or the "Company") (NASDAQ: CDIO), today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025. The ...

CELUS, developer of the leading AI-assisted electronics design platform used by developers and engineers globally, announced today that AGS Devices, a premier independent distributor of electronic ...

New data collected by DNSFilter from its DNS content filtering and threat blocking platform underscores the fraud risks that consumers face when researching summer vacation plans. Bad actors are ...

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceuticals – developed based on artificial platelet technology from ...

Texas Methodist Foundation announces Brandon Perry as vice president of lending. With nearly 20 years of experience as a commercial banking officer, helping clients with diverse needs and situations, ...

C, with USB-A variants scheduled for release by end of Q2 2025. All models support NFC for contactless use. The portfolio consists of three main lines: iShield Key 2, iShield Key 2 MIFARE, and iShield ...

About Arcadia Biosciences, Inc. Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today reported operational highlights and ...